Keun Ho Park

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial

Joo Myung Lee, Hyun Kuk Kim, Keun Ho Park et al. · European Heart Journal · 2022 · 163 citations

Medicine, Cardiology, Cardiothoracic Surgery +16

Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease

Sung‐Jin Hong, Yong‐Joon Lee, Seung‐Jun Lee et al. · JAMA · 2023 · 107 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Kyung Hoon Cho, Myung Ho Jeong, Daisuke Hachinohe et al. · The American Journal of Cardiology · 2011 · 102 citations

Medicine, Cardiology, Hematology +12